The Rates of Overtreatment and Deintensification in Patients With Diabetes Mellitus

Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

NCT00603031 ·Status: COMPLETED ·Phase: NA

Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

NCT00935805 ·Status: UNKNOWN

C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes

NCT04005261 ·Status: COMPLETED

Prevention of Metabolic Complications of Glucocorticoid Excess

NCT01319994 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus

NCT04430946 ·Status: UNKNOWN ·Phase: NA

Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

NCT02060383 ·Status: COMPLETED ·Phase: PHASE4

Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus

NCT00832741 ·Status: COMPLETED

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)

NCT04261933 ·Status: COMPLETED

Beta-Cell Function After Near-Normalisation of Blood Glucose

NCT00612950 ·Status: COMPLETED ·Phase: NA

Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes

NCT03509324 ·Status: COMPLETED ·Phase: PHASE4

Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes

NCT00704795 ·Status: UNKNOWN

Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass

NCT05057819 ·Status: COMPLETED ·Phase: PHASE4

β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed

NCT02199470 ·Status: COMPLETED

Hepatic Metabolic Changes in Response to Glucagon Infusion

NCT03526445 ·Status: COMPLETED ·Phase: NA

GLP-1 and Hypoglycemia

NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes

NCT04374578 ·Status: COMPLETED

Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.

NCT02877355 ·Status: COMPLETED ·Phase: PHASE1

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes

NCT01686945 ·Status: COMPLETED ·Phase: PHASE1

Study of Metformin Overdose

NCT04762966 ·Status: UNKNOWN

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

NCT00881543 ·Status: COMPLETED ·Phase: NA

Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

NCT01435980 ·Status: UNKNOWN ·Phase: PHASE4

A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism

NCT02604485 ·Status: COMPLETED ·Phase: PHASE2

The Glucagonotropic Effect of Amino Acids in Humans

NCT05954923 ·Status: COMPLETED ·Phase: NA

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

NCT00612625 ·Status: COMPLETED ·Phase: NA

Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options

NCT02365740 ·Status: UNKNOWN ·Phase: NA